Hypothyroid women on long-term levothyroxine therapy showed signs of increased bone turnover and increased resorptive changes, though not frank osteoporosis. Hence, it may be important to evaluate the bone status of patients on levothyroxine for >5 years.
Keyphrases
- bone mineral density
- postmenopausal women
- end stage renal disease
- polycystic ovary syndrome
- body composition
- ejection fraction
- soft tissue
- chronic kidney disease
- bone loss
- newly diagnosed
- pregnancy outcomes
- bone regeneration
- breast cancer risk
- peritoneal dialysis
- prognostic factors
- stem cells
- pregnant women
- metabolic syndrome
- mesenchymal stem cells
- skeletal muscle
- patient reported outcomes
- replacement therapy
- early breast cancer